Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

STONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc.(NASDAQ:APDN) (Applied DNA), a leader in ...

Ethris has partnered Lonza for the development of room-temperature stable mRNA vaccine candidates targeting respiratory ...

The FDA has granted clearance to CureVac's IND for the open-label Phase I trial of CVHNLC in individuals with sqNSCLC.

A team of researchers led by Dr. KIM V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of ...

The cap analog (3-OMe-GAG, CA-1006, Glycogene) was co-transcribed into mRNA strands. The IVT reaction was quenched by adding 100 units of DNase I (GMP-E127, Novoprotein). All mRNAs were purified using ...

Similarly, investors should look for DEI to open 1.16% lower in price and for IVT to open 0.81% lower, all else being equal. Below are dividend history charts for AHR, DEI, and IVT, showing ...

MRNA, NVAX Price Action: At the time of publication, Moderna shares were down 5.70% at $31.91 and Novavax shares were down 3.37% at $7.30, according to Benzinga Pro.

Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against ...

They found that mRNA-based COVID-19-vaccinations cause a significant and persistent change through acetylation, i.e., the binding of a chemical group to specific, immunologically relevant genes of ...